Condition
POAG
Total Trials
5
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Unknown4
Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT06691555Recruiting
Long-term Safety and Efficacy of a Modified Suprachoroidal Silicone Tube (SST) Shunt
NCT05062668UnknownPrimary
Efficacy and Safety of iStent Inject and Inject W in the Management of Primary Open-angle Glaucoma
NCT05278299UnknownPrimary
Asia Glaucoma Registry
NCT02792803Phase 4UnknownPrimary
A Comparison of Xalatan (Latanoprost) to Apo-latanoprost and Co-latanoprost in the Treatment of Glaucoma
NCT02312362Not ApplicableUnknown
High Frequency Deep Sclerotomy (HFDS) ab Interno a Combination Surgical Intervention Using Cataract Surgery to Lower IOP
Showing all 5 trials